CHG-2023-0166

New Dosage Strength for Retinavab. Manufacturing Process Change for Retinavab — minor update. Impacts 3 markets and 1 variations.

Change Number
CHG-2023-0166
Type
New Dosage Strength
Product
Retinavab
Status
Active
Owner
Tomoko Ikeda
Initiated
2022-10-04
Description

Manufacturing Process Change for Retinavab — minor update

Impacted Markets (3)
CN — ChinaAU — AustraliaBE — Belgium
Impacted Modules
3.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved